Category: Courts/First Amendment

Jury Says “Not Guilty” to Off-label Charges in Medical Device Case

Industry More Than Ready for FDA Off-label Communications Guidance

Industry Prepares for DTC Battle

Pacira Prevails in Exparel Settlement with FDA

Which Standard of Truth Will Be Used To Evaluate Non-misleading Ad Claims?

Pacira Files Complaint Calling FDA Marketing Restrictions Unconstitutional

Amarin Federal Court Decision: FDA Off-Label Marketing Rules Violate the First Amendment By John Kamp

House Energy and Commerce Committee Wholeheartedly Approves 21st Century Cures Act

21st Century Cures Legislation Poised for Full House Committee Vote This Week